Mid-Term Remission of Type 2 Diabetes Mellitus After Laparoscopic Roux En-Y Gastric Bypass

Laparoscopic Roux en-Y Gastric Bypass Using a Modified Retrocolic–Supracolic Approach: Outcomes from 300 Patients

(2016) Waleed Al-Khyatt et al.   WORLD JOURNAL OF SURGERY

Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery

(2015) Michael Taulo Lund et al.   JOURNAL OF PHYSIOLOGY-LONDON

Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

(2015) Geltrude Mingrone et al.   LANCET

Adults with long-duration type 2 diabetes have blunted glycemic andβ-Cell function improvements after bariatric surgery

(2015) Vishesh Khanna et al.   Obesity

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

(2014) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Different Criteria on Type 2 Diabetes Remission Rate After Bariatric Surgery

(2014) A. Mas-Lorenzo et al.   OBESITY SURGERY

Long-Term Effects of Laparoscopic Roux-en-Y Gastric Bypass on Diabetes Mellitus, Hypertension and Dyslipidaemia in Morbidly Obese Patients

(2014) K. Dogan et al.   OBESITY SURGERY

Outcomes of linear-stapled versus hand-sewn gastrojejunal anastomosis in laparoscopic Roux en-Y gastric bypass

(2014) Sherif Awad et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

A Meta-Analysis of Short-Term Outcomes of Patients with Type 2 Diabetes Mellitus and BMI ≤35 kg/m2 Undergoing Roux-en-Y Gastric Bypass

(2014) Wen-Sheng Rao et al.   WORLD JOURNAL OF SURGERY

Limited Recovery of  -Cell Function After Gastric Bypass Despite Clinical Diabetes Remission

(2013) R. Dutia et al.   DIABETES

Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia

(2013) Sayeed Ikramuddin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Which criteria should be used to define type 2 diabetes remission after bariatric surgery?

(2013) Ana M Ramos-Levi et al.   BMC Surgery

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

(2012) N. B. Jørgensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

(2012) N. Hex et al.   DIABETIC MEDICINE

Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes

(2012) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes

(2012) Geltrude Mingrone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

(2011) D. J. Pournaras et al.   BRITISH JOURNAL OF SURGERY

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

(2011) E. L. Lim et al.   DIABETOLOGIA

Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up

(2010) Kelvin Higa et al.   Surgery for Obesity and Related Diseases

Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis

(2009) Henry Buchwald et al.   AMERICAN JOURNAL OF MEDICINE

How Do We Define Cure of Diabetes?

(2009) J. B. Buse et al.   DIABETES CARE

Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

(2009) S R Kashyap et al.   INTERNATIONAL JOURNAL OF OBESITY